nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—Tetany—Liotrix—hypothyroidism	0.0228	0.033	CcSEcCtD
Paliperidone—Muscle twitching—Liothyronine—hypothyroidism	0.0209	0.0303	CcSEcCtD
Paliperidone—Menstruation irregular—Dextrothyroxine—hypothyroidism	0.0182	0.0264	CcSEcCtD
Paliperidone—Menstruation irregular—Levothyroxine—hypothyroidism	0.0182	0.0264	CcSEcCtD
Paliperidone—HTR2A—cerebellar cortex—hypothyroidism	0.018	0.0796	CbGeAlD
Paliperidone—DRD1—nerve—hypothyroidism	0.0169	0.0749	CbGeAlD
Paliperidone—Throat tightness—Liotrix—hypothyroidism	0.0151	0.0219	CcSEcCtD
Paliperidone—Venous thrombosis—Liotrix—hypothyroidism	0.0137	0.0199	CcSEcCtD
Paliperidone—Menstruation irregular—Liotrix—hypothyroidism	0.0134	0.0194	CcSEcCtD
Paliperidone—DRD4—heart—hypothyroidism	0.0125	0.0553	CbGeAlD
Paliperidone—Intestinal obstruction—Liotrix—hypothyroidism	0.0109	0.0158	CcSEcCtD
Paliperidone—DRD2—nerve—hypothyroidism	0.00999	0.0443	CbGeAlD
Paliperidone—Wheezing—Levothyroxine—hypothyroidism	0.00979	0.0142	CcSEcCtD
Paliperidone—Wheezing—Dextrothyroxine—hypothyroidism	0.00979	0.0142	CcSEcCtD
Paliperidone—HTR2A—urine—hypothyroidism	0.00954	0.0423	CbGeAlD
Paliperidone—CYP3A4—urine—hypothyroidism	0.00884	0.0392	CbGeAlD
Paliperidone—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.00879	0.0128	CcSEcCtD
Paliperidone—Hyperkinesia—Levothyroxine—hypothyroidism	0.00879	0.0128	CcSEcCtD
Paliperidone—CYP2D6—urine—hypothyroidism	0.00869	0.0385	CbGeAlD
Paliperidone—Cellulitis—Liotrix—hypothyroidism	0.00815	0.0118	CcSEcCtD
Paliperidone—Increased appetite—Dextrothyroxine—hypothyroidism	0.00779	0.0113	CcSEcCtD
Paliperidone—Increased appetite—Levothyroxine—hypothyroidism	0.00779	0.0113	CcSEcCtD
Paliperidone—Hypertension—Liothyronine—hypothyroidism	0.00775	0.0112	CcSEcCtD
Paliperidone—DRD4—testis—hypothyroidism	0.0077	0.0341	CbGeAlD
Paliperidone—Muscle twitching—Liotrix—hypothyroidism	0.00755	0.011	CcSEcCtD
Paliperidone—Hypoglycaemia—Levothyroxine—hypothyroidism	0.0075	0.0109	CcSEcCtD
Paliperidone—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.0075	0.0109	CcSEcCtD
Paliperidone—Wheezing—Liotrix—hypothyroidism	0.0072	0.0105	CcSEcCtD
Paliperidone—Tachycardia—Liothyronine—hypothyroidism	0.00715	0.0104	CcSEcCtD
Paliperidone—Fluid retention—Liotrix—hypothyroidism	0.00704	0.0102	CcSEcCtD
Paliperidone—Cardiac arrest—Levothyroxine—hypothyroidism	0.00696	0.0101	CcSEcCtD
Paliperidone—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00696	0.0101	CcSEcCtD
Paliperidone—Hypotension—Liothyronine—hypothyroidism	0.00684	0.00993	CcSEcCtD
Paliperidone—HTR2A—nerve—hypothyroidism	0.00659	0.0292	CbGeAlD
Paliperidone—Hyperkinesia—Liotrix—hypothyroidism	0.00647	0.00939	CcSEcCtD
Paliperidone—Muscular weakness—Levothyroxine—hypothyroidism	0.00645	0.00937	CcSEcCtD
Paliperidone—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00645	0.00937	CcSEcCtD
Paliperidone—Dysphagia—Levothyroxine—hypothyroidism	0.00633	0.00918	CcSEcCtD
Paliperidone—Dysphagia—Dextrothyroxine—hypothyroidism	0.00633	0.00918	CcSEcCtD
Paliperidone—Swelling—Liotrix—hypothyroidism	0.0061	0.00886	CcSEcCtD
Paliperidone—Body temperature increased—Liothyronine—hypothyroidism	0.00579	0.0084	CcSEcCtD
Paliperidone—Increased appetite—Liotrix—hypothyroidism	0.00573	0.00832	CcSEcCtD
Paliperidone—Weight decreased—Dextrothyroxine—hypothyroidism	0.00572	0.00831	CcSEcCtD
Paliperidone—Weight decreased—Levothyroxine—hypothyroidism	0.00572	0.00831	CcSEcCtD
Paliperidone—Hypoglycaemia—Liotrix—hypothyroidism	0.00552	0.00801	CcSEcCtD
Paliperidone—Cerebrovascular accident—Liotrix—hypothyroidism	0.00549	0.00797	CcSEcCtD
Paliperidone—Cardiac arrest—Liotrix—hypothyroidism	0.00512	0.00743	CcSEcCtD
Paliperidone—HTR1B—cardiovascular system—hypothyroidism	0.0048	0.0213	CbGeAlD
Paliperidone—Muscular weakness—Liotrix—hypothyroidism	0.00475	0.00689	CcSEcCtD
Paliperidone—Flushing—Levothyroxine—hypothyroidism	0.0047	0.00682	CcSEcCtD
Paliperidone—Flushing—Dextrothyroxine—hypothyroidism	0.0047	0.00682	CcSEcCtD
Paliperidone—Dysphagia—Liotrix—hypothyroidism	0.00465	0.00675	CcSEcCtD
Paliperidone—HTR1D—cardiovascular system—hypothyroidism	0.00465	0.0206	CbGeAlD
Paliperidone—Bronchitis—Liotrix—hypothyroidism	0.00447	0.00649	CcSEcCtD
Paliperidone—Alopecia—Dextrothyroxine—hypothyroidism	0.00447	0.00649	CcSEcCtD
Paliperidone—Alopecia—Levothyroxine—hypothyroidism	0.00447	0.00649	CcSEcCtD
Paliperidone—Tension—Dextrothyroxine—hypothyroidism	0.00432	0.00628	CcSEcCtD
Paliperidone—Tension—Levothyroxine—hypothyroidism	0.00432	0.00628	CcSEcCtD
Paliperidone—Nervousness—Levothyroxine—hypothyroidism	0.00428	0.00621	CcSEcCtD
Paliperidone—Nervousness—Dextrothyroxine—hypothyroidism	0.00428	0.00621	CcSEcCtD
Paliperidone—Weight decreased—Liotrix—hypothyroidism	0.00421	0.00611	CcSEcCtD
Paliperidone—Tremor—Levothyroxine—hypothyroidism	0.00413	0.00599	CcSEcCtD
Paliperidone—Tremor—Dextrothyroxine—hypothyroidism	0.00413	0.00599	CcSEcCtD
Paliperidone—Agitation—Dextrothyroxine—hypothyroidism	0.00405	0.00588	CcSEcCtD
Paliperidone—Agitation—Levothyroxine—hypothyroidism	0.00405	0.00588	CcSEcCtD
Paliperidone—Angioedema—Dextrothyroxine—hypothyroidism	0.00403	0.00584	CcSEcCtD
Paliperidone—Angioedema—Levothyroxine—hypothyroidism	0.00403	0.00584	CcSEcCtD
Paliperidone—Palpitations—Dextrothyroxine—hypothyroidism	0.00389	0.00565	CcSEcCtD
Paliperidone—Palpitations—Levothyroxine—hypothyroidism	0.00389	0.00565	CcSEcCtD
Paliperidone—HTR1A—cardiovascular system—hypothyroidism	0.00387	0.0172	CbGeAlD
Paliperidone—Convulsion—Levothyroxine—hypothyroidism	0.00382	0.00554	CcSEcCtD
Paliperidone—Convulsion—Dextrothyroxine—hypothyroidism	0.00382	0.00554	CcSEcCtD
Paliperidone—ADRA1A—heart—hypothyroidism	0.00378	0.0168	CbGeAlD
Paliperidone—Arthralgia—Levothyroxine—hypothyroidism	0.00375	0.00545	CcSEcCtD
Paliperidone—Arthralgia—Dextrothyroxine—hypothyroidism	0.00375	0.00545	CcSEcCtD
Paliperidone—Anxiety—Levothyroxine—hypothyroidism	0.00374	0.00543	CcSEcCtD
Paliperidone—Anxiety—Dextrothyroxine—hypothyroidism	0.00374	0.00543	CcSEcCtD
Paliperidone—ADRA2C—adrenal cortex—hypothyroidism	0.00373	0.0165	CbGeAlD
Paliperidone—Hypoaesthesia—Liotrix—hypothyroidism	0.00371	0.00538	CcSEcCtD
Paliperidone—Confusional state—Dextrothyroxine—hypothyroidism	0.00363	0.00526	CcSEcCtD
Paliperidone—Confusional state—Levothyroxine—hypothyroidism	0.00363	0.00526	CcSEcCtD
Paliperidone—ADRA2C—heart—hypothyroidism	0.0036	0.016	CbGeAlD
Paliperidone—ADRA1A—cardiovascular system—hypothyroidism	0.00357	0.0158	CbGeAlD
Paliperidone—Shock—Levothyroxine—hypothyroidism	0.00354	0.00514	CcSEcCtD
Paliperidone—Shock—Dextrothyroxine—hypothyroidism	0.00354	0.00514	CcSEcCtD
Paliperidone—Tachycardia—Levothyroxine—hypothyroidism	0.00351	0.0051	CcSEcCtD
Paliperidone—Tachycardia—Dextrothyroxine—hypothyroidism	0.00351	0.0051	CcSEcCtD
Paliperidone—Flushing—Liotrix—hypothyroidism	0.00346	0.00502	CcSEcCtD
Paliperidone—Alopecia—Liotrix—hypothyroidism	0.00329	0.00478	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00328	0.00476	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00328	0.00476	CcSEcCtD
Paliperidone—Insomnia—Levothyroxine—hypothyroidism	0.00325	0.00472	CcSEcCtD
Paliperidone—Insomnia—Dextrothyroxine—hypothyroidism	0.00325	0.00472	CcSEcCtD
Paliperidone—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00321	0.00465	CcSEcCtD
Paliperidone—Dyspnoea—Levothyroxine—hypothyroidism	0.00321	0.00465	CcSEcCtD
Paliperidone—Flatulence—Liotrix—hypothyroidism	0.00319	0.00464	CcSEcCtD
Paliperidone—Tension—Liotrix—hypothyroidism	0.00318	0.00462	CcSEcCtD
Paliperidone—Dysgeusia—Liotrix—hypothyroidism	0.00317	0.00461	CcSEcCtD
Paliperidone—Nervousness—Liotrix—hypothyroidism	0.00315	0.00457	CcSEcCtD
Paliperidone—Fatigue—Levothyroxine—hypothyroidism	0.0031	0.0045	CcSEcCtD
Paliperidone—Fatigue—Dextrothyroxine—hypothyroidism	0.0031	0.0045	CcSEcCtD
Paliperidone—DRD2—pituitary gland—hypothyroidism	0.0031	0.0137	CbGeAlD
Paliperidone—HTR1A—adrenal gland—hypothyroidism	0.00306	0.0136	CbGeAlD
Paliperidone—Vision blurred—Liotrix—hypothyroidism	0.00306	0.00443	CcSEcCtD
Paliperidone—Tremor—Liotrix—hypothyroidism	0.00304	0.00441	CcSEcCtD
Paliperidone—ADRA2C—pituitary gland—hypothyroidism	0.00301	0.0134	CbGeAlD
Paliperidone—Agitation—Liotrix—hypothyroidism	0.00298	0.00432	CcSEcCtD
Paliperidone—Feeling abnormal—Levothyroxine—hypothyroidism	0.00296	0.0043	CcSEcCtD
Paliperidone—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00296	0.0043	CcSEcCtD
Paliperidone—Angioedema—Liotrix—hypothyroidism	0.00296	0.0043	CcSEcCtD
Paliperidone—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00294	0.00427	CcSEcCtD
Paliperidone—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00294	0.00427	CcSEcCtD
Paliperidone—Syncope—Liotrix—hypothyroidism	0.00291	0.00422	CcSEcCtD
Paliperidone—ADRA2A—heart—hypothyroidism	0.00288	0.0127	CbGeAlD
Paliperidone—Palpitations—Liotrix—hypothyroidism	0.00286	0.00416	CcSEcCtD
Paliperidone—Urticaria—Levothyroxine—hypothyroidism	0.00286	0.00415	CcSEcCtD
Paliperidone—Urticaria—Dextrothyroxine—hypothyroidism	0.00286	0.00415	CcSEcCtD
Paliperidone—Loss of consciousness—Liotrix—hypothyroidism	0.00285	0.00414	CcSEcCtD
Paliperidone—Body temperature increased—Levothyroxine—hypothyroidism	0.00284	0.00413	CcSEcCtD
Paliperidone—Abdominal pain—Levothyroxine—hypothyroidism	0.00284	0.00413	CcSEcCtD
Paliperidone—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00284	0.00413	CcSEcCtD
Paliperidone—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00284	0.00413	CcSEcCtD
Paliperidone—ADRA1A—adrenal gland—hypothyroidism	0.00282	0.0125	CbGeAlD
Paliperidone—ADRA1A—blood—hypothyroidism	0.00282	0.0125	CbGeAlD
Paliperidone—Convulsion—Liotrix—hypothyroidism	0.00281	0.00408	CcSEcCtD
Paliperidone—Hypertension—Liotrix—hypothyroidism	0.0028	0.00406	CcSEcCtD
Paliperidone—Arthralgia—Liotrix—hypothyroidism	0.00276	0.00401	CcSEcCtD
Paliperidone—Chest pain—Liotrix—hypothyroidism	0.00276	0.00401	CcSEcCtD
Paliperidone—Anxiety—Liotrix—hypothyroidism	0.00275	0.00399	CcSEcCtD
Paliperidone—ADRA2C—adrenal gland—hypothyroidism	0.00269	0.0119	CbGeAlD
Paliperidone—ADRA2C—blood—hypothyroidism	0.00269	0.0119	CbGeAlD
Paliperidone—Confusional state—Liotrix—hypothyroidism	0.00267	0.00387	CcSEcCtD
Paliperidone—Anaphylactic shock—Liotrix—hypothyroidism	0.00265	0.00384	CcSEcCtD
Paliperidone—Oedema—Liotrix—hypothyroidism	0.00265	0.00384	CcSEcCtD
Paliperidone—Infection—Liotrix—hypothyroidism	0.00263	0.00382	CcSEcCtD
Paliperidone—Shock—Liotrix—hypothyroidism	0.0026	0.00378	CcSEcCtD
Paliperidone—Tachycardia—Liotrix—hypothyroidism	0.00258	0.00375	CcSEcCtD
Paliperidone—Asthenia—Levothyroxine—hypothyroidism	0.00258	0.00375	CcSEcCtD
Paliperidone—Asthenia—Dextrothyroxine—hypothyroidism	0.00258	0.00375	CcSEcCtD
Paliperidone—Pruritus—Levothyroxine—hypothyroidism	0.00254	0.00369	CcSEcCtD
Paliperidone—Pruritus—Dextrothyroxine—hypothyroidism	0.00254	0.00369	CcSEcCtD
Paliperidone—Anorexia—Liotrix—hypothyroidism	0.00252	0.00366	CcSEcCtD
Paliperidone—ADRA2C—female gonad—hypothyroidism	0.00251	0.0111	CbGeAlD
Paliperidone—Hypotension—Liotrix—hypothyroidism	0.00247	0.00359	CcSEcCtD
Paliperidone—ADRA2A—gonad—hypothyroidism	0.00246	0.0109	CbGeAlD
Paliperidone—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00246	0.00357	CcSEcCtD
Paliperidone—Diarrhoea—Levothyroxine—hypothyroidism	0.00246	0.00357	CcSEcCtD
Paliperidone—HTR2A—heart—hypothyroidism	0.00245	0.0108	CbGeAlD
Paliperidone—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00241	0.0035	CcSEcCtD
Paliperidone—ADRA2A—pituitary gland—hypothyroidism	0.0024	0.0107	CbGeAlD
Paliperidone—Insomnia—Liotrix—hypothyroidism	0.00239	0.00347	CcSEcCtD
Paliperidone—Paraesthesia—Liotrix—hypothyroidism	0.00238	0.00345	CcSEcCtD
Paliperidone—Dyspnoea—Liotrix—hypothyroidism	0.00236	0.00342	CcSEcCtD
Paliperidone—HTR1A—cerebellum—hypothyroidism	0.00234	0.0104	CbGeAlD
Paliperidone—HTR2A—cardiovascular system—hypothyroidism	0.00231	0.0102	CbGeAlD
Paliperidone—Decreased appetite—Liotrix—hypothyroidism	0.0023	0.00334	CcSEcCtD
Paliperidone—DRD2—testis—hypothyroidism	0.00229	0.0101	CbGeAlD
Paliperidone—Vomiting—Levothyroxine—hypothyroidism	0.00229	0.00332	CcSEcCtD
Paliperidone—Vomiting—Dextrothyroxine—hypothyroidism	0.00229	0.00332	CcSEcCtD
Paliperidone—Fatigue—Liotrix—hypothyroidism	0.00228	0.00331	CcSEcCtD
Paliperidone—Rash—Levothyroxine—hypothyroidism	0.00227	0.00329	CcSEcCtD
Paliperidone—Rash—Dextrothyroxine—hypothyroidism	0.00227	0.00329	CcSEcCtD
Paliperidone—Dermatitis—Levothyroxine—hypothyroidism	0.00227	0.00329	CcSEcCtD
Paliperidone—Dermatitis—Dextrothyroxine—hypothyroidism	0.00227	0.00329	CcSEcCtD
Paliperidone—Constipation—Liotrix—hypothyroidism	0.00226	0.00328	CcSEcCtD
Paliperidone—Headache—Dextrothyroxine—hypothyroidism	0.00225	0.00327	CcSEcCtD
Paliperidone—Headache—Levothyroxine—hypothyroidism	0.00225	0.00327	CcSEcCtD
Paliperidone—CYP3A5—blood—hypothyroidism	0.00225	0.00998	CbGeAlD
Paliperidone—ADRA2C—testis—hypothyroidism	0.00222	0.00986	CbGeAlD
Paliperidone—ADRA1A—liver—hypothyroidism	0.00221	0.00979	CbGeAlD
Paliperidone—HRH1—adrenal gland—hypothyroidism	0.00219	0.00969	CbGeAlD
Paliperidone—Feeling abnormal—Liotrix—hypothyroidism	0.00218	0.00316	CcSEcCtD
Paliperidone—Gastrointestinal pain—Liotrix—hypothyroidism	0.00216	0.00314	CcSEcCtD
Paliperidone—ADRA1A—cerebellum—hypothyroidism	0.00216	0.00956	CbGeAlD
Paliperidone—ADRA2A—adrenal gland—hypothyroidism	0.00215	0.00952	CbGeAlD
Paliperidone—ADRA2A—blood—hypothyroidism	0.00215	0.00951	CbGeAlD
Paliperidone—Nausea—Levothyroxine—hypothyroidism	0.00214	0.0031	CcSEcCtD
Paliperidone—Nausea—Dextrothyroxine—hypothyroidism	0.00214	0.0031	CcSEcCtD
Paliperidone—DRD2—cerebellum—hypothyroidism	0.00211	0.00937	CbGeAlD
Paliperidone—ADRA2C—liver—hypothyroidism	0.0021	0.00932	CbGeAlD
Paliperidone—Urticaria—Liotrix—hypothyroidism	0.0021	0.00305	CcSEcCtD
Paliperidone—CYP3A5—female gonad—hypothyroidism	0.0021	0.00931	CbGeAlD
Paliperidone—HTR2A—gonad—hypothyroidism	0.00209	0.00928	CbGeAlD
Paliperidone—Body temperature increased—Liotrix—hypothyroidism	0.00209	0.00304	CcSEcCtD
Paliperidone—Abdominal pain—Liotrix—hypothyroidism	0.00209	0.00304	CcSEcCtD
Paliperidone—ADRA2A—thyroid gland—hypothyroidism	0.00207	0.00918	CbGeAlD
Paliperidone—ADRA2C—cerebellum—hypothyroidism	0.00205	0.00911	CbGeAlD
Paliperidone—HTR2A—pituitary gland—hypothyroidism	0.00204	0.00906	CbGeAlD
Paliperidone—HRH1—female gonad—hypothyroidism	0.00204	0.00903	CbGeAlD
Paliperidone—ADRA2A—female gonad—hypothyroidism	0.002	0.00887	CbGeAlD
Paliperidone—Hypersensitivity—Liotrix—hypothyroidism	0.00195	0.00283	CcSEcCtD
Paliperidone—Asthenia—Liotrix—hypothyroidism	0.0019	0.00276	CcSEcCtD
Paliperidone—Pruritus—Liotrix—hypothyroidism	0.00187	0.00272	CcSEcCtD
Paliperidone—HTR2A—adrenal gland—hypothyroidism	0.00183	0.00809	CbGeAlD
Paliperidone—HTR2A—blood—hypothyroidism	0.00182	0.00809	CbGeAlD
Paliperidone—Diarrhoea—Liotrix—hypothyroidism	0.00181	0.00263	CcSEcCtD
Paliperidone—HRH1—testis—hypothyroidism	0.00181	0.00801	CbGeAlD
Paliperidone—ADRA2A—testis—hypothyroidism	0.00178	0.00787	CbGeAlD
Paliperidone—CYP3A5—liver—hypothyroidism	0.00176	0.0078	CbGeAlD
Paliperidone—Dizziness—Liotrix—hypothyroidism	0.00175	0.00254	CcSEcCtD
Paliperidone—CYP3A4—blood—hypothyroidism	0.00169	0.00749	CbGeAlD
Paliperidone—Vomiting—Liotrix—hypothyroidism	0.00168	0.00244	CcSEcCtD
Paliperidone—Rash—Liotrix—hypothyroidism	0.00167	0.00242	CcSEcCtD
Paliperidone—Dermatitis—Liotrix—hypothyroidism	0.00167	0.00242	CcSEcCtD
Paliperidone—CYP2D6—blood—hypothyroidism	0.00166	0.00737	CbGeAlD
Paliperidone—Headache—Liotrix—hypothyroidism	0.00166	0.00241	CcSEcCtD
Paliperidone—ADRA2A—cerebellum—hypothyroidism	0.00164	0.00727	CbGeAlD
Paliperidone—Nausea—Liotrix—hypothyroidism	0.00157	0.00228	CcSEcCtD
Paliperidone—CYP2D6—female gonad—hypothyroidism	0.00155	0.00687	CbGeAlD
Paliperidone—HTR2A—testis—hypothyroidism	0.00151	0.00669	CbGeAlD
Paliperidone—HTR2A—liver—hypothyroidism	0.00143	0.00633	CbGeAlD
Paliperidone—HTR2A—cerebellum—hypothyroidism	0.00139	0.00618	CbGeAlD
Paliperidone—CYP2D6—testis—hypothyroidism	0.00138	0.0061	CbGeAlD
Paliperidone—CYP3A4—liver—hypothyroidism	0.00132	0.00586	CbGeAlD
Paliperidone—CYP2D6—liver—hypothyroidism	0.0013	0.00576	CbGeAlD
Paliperidone—CYP2D6—cerebellum—hypothyroidism	0.00127	0.00563	CbGeAlD
Paliperidone—DRD1—Signaling Pathways—TRH—hypothyroidism	8.97e-05	0.00105	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CLTC—hypothyroidism	8.93e-05	0.00104	CbGpPWpGaD
Paliperidone—HTR1A—GPCR ligand binding—POMC—hypothyroidism	8.88e-05	0.00104	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TSHB—hypothyroidism	8.88e-05	0.00104	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TSHR—hypothyroidism	8.88e-05	0.00104	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CLTC—hypothyroidism	8.88e-05	0.00104	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—AVP—hypothyroidism	8.86e-05	0.00104	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TRH—hypothyroidism	8.85e-05	0.00104	CbGpPWpGaD
Paliperidone—HTR2C—GPCR ligand binding—POMC—hypothyroidism	8.84e-05	0.00103	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—AVP—hypothyroidism	8.78e-05	0.00103	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—AVP—hypothyroidism	8.67e-05	0.00101	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CLTC—hypothyroidism	8.64e-05	0.00101	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR ligand binding—POMC—hypothyroidism	8.6e-05	0.00101	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CLTC—hypothyroidism	8.5e-05	0.000995	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR ligand binding—POMC—hypothyroidism	8.46e-05	0.00099	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—VAV3—hypothyroidism	8.28e-05	0.000969	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—SH2B3—hypothyroidism	8.22e-05	0.000961	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—VAV3—hypothyroidism	8.17e-05	0.000956	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—VAV3—hypothyroidism	8.12e-05	0.00095	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—SH2B3—hypothyroidism	8.05e-05	0.000941	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TSHB—hypothyroidism	8e-05	0.000936	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TSHR—hypothyroidism	8e-05	0.000936	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TRH—hypothyroidism	7.99e-05	0.000935	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—AVP—hypothyroidism	7.98e-05	0.000933	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—TSHB—hypothyroidism	7.96e-05	0.000931	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—SH2B3—hypothyroidism	7.92e-05	0.000926	CbGpPWpGaD
Paliperidone—ADRA2B—Hemostasis—IGF1—hypothyroidism	7.92e-05	0.000926	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TSHB—hypothyroidism	7.89e-05	0.000923	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TSHR—hypothyroidism	7.89e-05	0.000923	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—AVP—hypothyroidism	7.87e-05	0.000921	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—VAV3—hypothyroidism	7.84e-05	0.000917	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CLTC—hypothyroidism	7.84e-05	0.000917	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—AVP—hypothyroidism	7.83e-05	0.000916	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—VAV3—hypothyroidism	7.8e-05	0.000913	CbGpPWpGaD
Paliperidone—DRD2—GPCR ligand binding—POMC—hypothyroidism	7.8e-05	0.000913	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TRH—hypothyroidism	7.71e-05	0.000903	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CLTC—hypothyroidism	7.71e-05	0.000902	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CLTC—hypothyroidism	7.69e-05	0.0009	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TRH—hypothyroidism	7.67e-05	0.000898	CbGpPWpGaD
Paliperidone—HTR2A—GPCR ligand binding—POMC—hypothyroidism	7.67e-05	0.000898	CbGpPWpGaD
Paliperidone—HRH1—GPCR ligand binding—POMC—hypothyroidism	7.66e-05	0.000896	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—VAV3—hypothyroidism	7.59e-05	0.000888	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—AVP—hypothyroidism	7.55e-05	0.000884	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CLTC—hypothyroidism	7.55e-05	0.000883	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—AVP—hypothyroidism	7.52e-05	0.000879	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR ligand binding—POMC—hypothyroidism	7.51e-05	0.000879	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—VAV3—hypothyroidism	7.47e-05	0.000874	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TRH—hypothyroidism	7.46e-05	0.000873	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—IYD—hypothyroidism	7.44e-05	0.00087	CbGpPWpGaD
Paliperidone—ADRA2C—Hemostasis—IGF1—hypothyroidism	7.39e-05	0.000865	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—VAV3—hypothyroidism	7.38e-05	0.000863	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TRH—hypothyroidism	7.35e-05	0.00086	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—AVP—hypothyroidism	7.31e-05	0.000855	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—AVP—hypothyroidism	7.19e-05	0.000842	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—SH2B3—hypothyroidism	7.13e-05	0.000834	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TSHR—hypothyroidism	7.12e-05	0.000833	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TSHB—hypothyroidism	7.12e-05	0.000833	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—VAV3—hypothyroidism	7.12e-05	0.000833	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—AVP—hypothyroidism	7.11e-05	0.000831	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—PIK3C2A—hypothyroidism	7.09e-05	0.00083	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—VAV3—hypothyroidism	7.08e-05	0.000829	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—SH2B3—hypothyroidism	7.03e-05	0.000823	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CLTC—hypothyroidism	7.02e-05	0.000821	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR ligand binding—POMC—hypothyroidism	6.98e-05	0.000817	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—VAV3—hypothyroidism	6.89e-05	0.000806	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—VAV3—hypothyroidism	6.88e-05	0.000805	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TSHR—hypothyroidism	6.88e-05	0.000804	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TSHB—hypothyroidism	6.88e-05	0.000804	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—AVP—hypothyroidism	6.86e-05	0.000803	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TSHB—hypothyroidism	6.84e-05	0.0008	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TSHR—hypothyroidism	6.84e-05	0.0008	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—AVP—hypothyroidism	6.82e-05	0.000799	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—VAV3—hypothyroidism	6.78e-05	0.000793	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—VAV3—hypothyroidism	6.77e-05	0.000793	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TRH—hypothyroidism	6.77e-05	0.000792	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—VAV3—hypothyroidism	6.76e-05	0.000791	CbGpPWpGaD
Paliperidone—HTR1D—GPCR downstream signaling—POMC—hypothyroidism	6.73e-05	0.000787	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TRH—hypothyroidism	6.66e-05	0.00078	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TSHB—hypothyroidism	6.65e-05	0.000778	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TSHR—hypothyroidism	6.65e-05	0.000778	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TRH—hypothyroidism	6.65e-05	0.000778	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—AVP—hypothyroidism	6.64e-05	0.000777	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—VAV3—hypothyroidism	6.63e-05	0.000776	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—AVP—hypothyroidism	6.63e-05	0.000776	CbGpPWpGaD
Paliperidone—HTR1B—GPCR downstream signaling—POMC—hypothyroidism	6.59e-05	0.000771	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TSHB—hypothyroidism	6.55e-05	0.000766	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TSHR—hypothyroidism	6.55e-05	0.000766	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—AVP—hypothyroidism	6.53e-05	0.000764	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—AVP—hypothyroidism	6.53e-05	0.000764	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TRH—hypothyroidism	6.53e-05	0.000764	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—AVP—hypothyroidism	6.51e-05	0.000762	CbGpPWpGaD
Paliperidone—DRD4—GPCR downstream signaling—POMC—hypothyroidism	6.48e-05	0.000759	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—TSHB—hypothyroidism	6.46e-05	0.000756	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—AVP—hypothyroidism	6.39e-05	0.000748	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—SH2B3—hypothyroidism	6.35e-05	0.000743	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ATP5O—hypothyroidism	6.33e-05	0.00074	CbGpPWpGaD
Paliperidone—CYP3A4—Biological oxidations—POMC—hypothyroidism	6.31e-05	0.000738	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—VAV3—hypothyroidism	6.25e-05	0.000731	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—VAV3—hypothyroidism	6.16e-05	0.000721	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—VAV3—hypothyroidism	6.15e-05	0.00072	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—VAV3—hypothyroidism	6.14e-05	0.000718	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—SH2B3—hypothyroidism	6.13e-05	0.000717	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—POMC—hypothyroidism	6.11e-05	0.000715	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—SH2B3—hypothyroidism	6.1e-05	0.000713	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—PRL—hypothyroidism	6.1e-05	0.000713	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TRH—hypothyroidism	6.06e-05	0.000709	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TSHR—hypothyroidism	6.04e-05	0.000706	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TSHB—hypothyroidism	6.04e-05	0.000706	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—VAV3—hypothyroidism	6.02e-05	0.000705	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—AVP—hypothyroidism	6.02e-05	0.000705	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—IGF1—hypothyroidism	6.01e-05	0.000703	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—POMC—hypothyroidism	5.98e-05	0.0007	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—PRL—hypothyroidism	5.97e-05	0.000698	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—SLC5A5—hypothyroidism	5.96e-05	0.000697	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—TPO—hypothyroidism	5.95e-05	0.000696	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TSHR—hypothyroidism	5.94e-05	0.000695	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TSHB—hypothyroidism	5.94e-05	0.000695	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—AVP—hypothyroidism	5.94e-05	0.000695	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—SH2B3—hypothyroidism	5.93e-05	0.000694	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TSHB—hypothyroidism	5.93e-05	0.000694	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TSHR—hypothyroidism	5.93e-05	0.000694	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—AVP—hypothyroidism	5.93e-05	0.000693	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—TSHB—hypothyroidism	5.92e-05	0.000693	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—AVP—hypothyroidism	5.91e-05	0.000692	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—POMC—hypothyroidism	5.89e-05	0.000689	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—PRL—hypothyroidism	5.87e-05	0.000687	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—POMC—hypothyroidism	5.84e-05	0.000683	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—SH2B3—hypothyroidism	5.84e-05	0.000683	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TSHB—hypothyroidism	5.82e-05	0.000681	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TSHR—hypothyroidism	5.82e-05	0.000681	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—AVP—hypothyroidism	5.8e-05	0.000679	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PIK3C2A—hypothyroidism	5.76e-05	0.000674	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—POMC—hypothyroidism	5.76e-05	0.000674	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—VAV3—hypothyroidism	5.64e-05	0.00066	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—VAV3—hypothyroidism	5.6e-05	0.000655	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—VAV3—hypothyroidism	5.52e-05	0.000646	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—VAV3—hypothyroidism	5.43e-05	0.000636	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—AVP—hypothyroidism	5.43e-05	0.000636	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TSHB—hypothyroidism	5.4e-05	0.000632	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TSHR—hypothyroidism	5.4e-05	0.000632	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—AVP—hypothyroidism	5.39e-05	0.000631	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—SH2B3—hypothyroidism	5.38e-05	0.00063	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—AVP—hypothyroidism	5.32e-05	0.000622	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—POMC—hypothyroidism	5.3e-05	0.00062	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—SH2B3—hypothyroidism	5.29e-05	0.000619	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—PRL—hypothyroidism	5.29e-05	0.000619	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—SH2B3—hypothyroidism	5.28e-05	0.000618	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	5.28e-05	0.000618	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—AVP—hypothyroidism	5.23e-05	0.000612	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—POMC—hypothyroidism	5.23e-05	0.000612	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—PRL—hypothyroidism	5.22e-05	0.00061	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—POMC—hypothyroidism	5.2e-05	0.000608	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—SH2B3—hypothyroidism	5.18e-05	0.000607	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—POMC—hypothyroidism	5.02e-05	0.000587	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—POMC—hypothyroidism	4.99e-05	0.000584	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—VAV3—hypothyroidism	4.89e-05	0.000572	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—POMC—hypothyroidism	4.86e-05	0.000568	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—SLC5A5—hypothyroidism	4.84e-05	0.000566	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—VAV3—hypothyroidism	4.83e-05	0.000565	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—SH2B3—hypothyroidism	4.82e-05	0.000564	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—POMC—hypothyroidism	4.78e-05	0.000559	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—POMC—hypothyroidism	4.72e-05	0.000553	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—AVP—hypothyroidism	4.71e-05	0.000551	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—PRL—hypothyroidism	4.71e-05	0.000551	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—AVP—hypothyroidism	4.65e-05	0.000544	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—POMC—hypothyroidism	4.56e-05	0.000533	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—PRL—hypothyroidism	4.55e-05	0.000532	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—POMC—hypothyroidism	4.54e-05	0.000531	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—PRL—hypothyroidism	4.52e-05	0.000529	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—SLC5A5—hypothyroidism	4.43e-05	0.000519	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—POMC—hypothyroidism	4.41e-05	0.000516	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—POMC—hypothyroidism	4.41e-05	0.000516	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—PRL—hypothyroidism	4.4e-05	0.000515	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—VAV3—hypothyroidism	4.36e-05	0.00051	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—POMC—hypothyroidism	4.34e-05	0.000508	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—POMC—hypothyroidism	4.34e-05	0.000507	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—PRL—hypothyroidism	4.33e-05	0.000507	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—POMC—hypothyroidism	4.33e-05	0.000506	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—POMC—hypothyroidism	4.25e-05	0.000497	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—TSHB—hypothyroidism	4.21e-05	0.000493	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—VAV3—hypothyroidism	4.21e-05	0.000492	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—AVP—hypothyroidism	4.2e-05	0.000491	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—VAV3—hypothyroidism	4.18e-05	0.00049	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—VAV3—hypothyroidism	4.07e-05	0.000476	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—AVP—hypothyroidism	4.05e-05	0.000474	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—AVP—hypothyroidism	4.03e-05	0.000472	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—VAV3—hypothyroidism	4.01e-05	0.000469	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—POMC—hypothyroidism	4e-05	0.000468	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—PRL—hypothyroidism	3.99e-05	0.000467	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—POMC—hypothyroidism	3.95e-05	0.000462	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—POMC—hypothyroidism	3.94e-05	0.000461	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—POMC—hypothyroidism	3.93e-05	0.00046	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—PRL—hypothyroidism	3.93e-05	0.00046	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—AVP—hypothyroidism	3.92e-05	0.000459	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—PRL—hypothyroidism	3.92e-05	0.000459	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—AVP—hypothyroidism	3.86e-05	0.000452	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—POMC—hypothyroidism	3.86e-05	0.000451	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—PRL—hypothyroidism	3.85e-05	0.00045	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	3.75e-05	0.000439	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—VAV3—hypothyroidism	3.69e-05	0.000432	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—VAV3—hypothyroidism	3.63e-05	0.000425	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—VAV3—hypothyroidism	3.63e-05	0.000424	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—POMC—hypothyroidism	3.61e-05	0.000422	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—POMC—hypothyroidism	3.58e-05	0.000419	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—PRL—hypothyroidism	3.57e-05	0.000418	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—VAV3—hypothyroidism	3.56e-05	0.000416	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—AVP—hypothyroidism	3.56e-05	0.000416	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—POMC—hypothyroidism	3.54e-05	0.000414	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—AVP—hypothyroidism	3.5e-05	0.00041	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—AVP—hypothyroidism	3.49e-05	0.000409	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—POMC—hypothyroidism	3.48e-05	0.000407	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IGF1—hypothyroidism	3.47e-05	0.000406	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—AVP—hypothyroidism	3.43e-05	0.000401	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IGF1—hypothyroidism	3.4e-05	0.000398	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IGF1—hypothyroidism	3.35e-05	0.000392	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—VAV3—hypothyroidism	3.31e-05	0.000387	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—AVP—hypothyroidism	3.19e-05	0.000373	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—SLC5A5—hypothyroidism	3.15e-05	0.000369	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—POMC—hypothyroidism	3.13e-05	0.000366	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—POMC—hypothyroidism	3.12e-05	0.000365	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—POMC—hypothyroidism	3.09e-05	0.000362	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IGF1—hypothyroidism	3.01e-05	0.000352	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IGF1—hypothyroidism	2.97e-05	0.000348	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—POMC—hypothyroidism	2.79e-05	0.000326	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—TSHB—hypothyroidism	2.75e-05	0.000322	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—POMC—hypothyroidism	2.69e-05	0.000315	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IGF1—hypothyroidism	2.68e-05	0.000314	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—POMC—hypothyroidism	2.68e-05	0.000313	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—POMC—hypothyroidism	2.61e-05	0.000305	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IGF1—hypothyroidism	2.59e-05	0.000303	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IGF1—hypothyroidism	2.58e-05	0.000302	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—POMC—hypothyroidism	2.56e-05	0.0003	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—POMC—hypothyroidism	2.53e-05	0.000296	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IGF1—hypothyroidism	2.51e-05	0.000293	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IGF1—hypothyroidism	2.47e-05	0.000289	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	2.45e-05	0.000287	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—POMC—hypothyroidism	2.36e-05	0.000277	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—POMC—hypothyroidism	2.33e-05	0.000272	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—POMC—hypothyroidism	2.32e-05	0.000272	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—POMC—hypothyroidism	2.32e-05	0.000271	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—POMC—hypothyroidism	2.28e-05	0.000267	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IGF1—hypothyroidism	2.27e-05	0.000266	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IGF1—hypothyroidism	2.24e-05	0.000262	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IGF1—hypothyroidism	2.23e-05	0.000261	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IGF1—hypothyroidism	2.19e-05	0.000256	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—POMC—hypothyroidism	2.12e-05	0.000248	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—SLC5A5—hypothyroidism	2.06e-05	0.000241	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IGF1—hypothyroidism	2.04e-05	0.000238	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—POMC—hypothyroidism	1.65e-05	0.000193	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—POMC—hypothyroidism	1.08e-05	0.000126	CbGpPWpGaD
